News From The Journal Of Clinical Investigation: March 26, 2012
ONCOLOGY Promise of new treatment options for chemotherapy-resistant breast cancers p53 is lost or functionally impaired in many human cancers, and its absence is often associated with a poor response to conventional chemotherapy. Thus, much effort is currently devoted to developing novel treatments for p53-deficient malignancies...
More... |
All times are GMT -7. The time now is 01:44 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021